VYNT

Vyant Bio, Inc. Common Stock
VYNT

Overview Fund Activity
Delisted

VYNT was delisted on the 12th of May, 2023.

Back to rankings

27 hedge funds and large institutions have $592K invested in Vyant Bio, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 3 closing their positions.

Holders
27
Holders Change
+1
Holders Change %
+3.85%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
10
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$220K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$53K
3
PP
3
Paloma Partners
Connecticut
$8K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$7K
5
UBS Group
5
UBS Group
Switzerland
$5K

Top Sellers

1
SCM
1
Stonepine Capital Management
Oregon
$0
2
PCM
2
Perkins Capital Management
Minnesota
$101K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$43K
4
VF
4
Virtu Financial
New York
$0
5
FCM
5
Fairbanks Capital Management
California
$20K
Name Market Value Shares Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
$0 1,000 -2,800 -74%
Barclays
27
Barclays
United Kingdom
$0 454 – –
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
Bank of America
29
Bank of America
North Carolina
$0 625 – –
Group One Trading
30
Group One Trading
Illinois
$0 100 +100 New
JPMorgan Chase & Co
31
JPMorgan Chase & Co
New York
$0 770 +770 New
1
2